SCHEMBL4595829

SCHEMBL4595829

CC[C@H](C)[C@H](N)C(=O)N(C)C

nearest known ligand 0.44

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 17/20 0.44
DPP8 Q6V1X1 10/20 0.44
DPP9 Q86TI2 9/20 0.44
DPP7 Q9UHL4 9/20 0.40
FAP Q12884 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL14779244 0.98 DPP4 (0.43) DPP4DPP8DPP9DPP7FAP
Hydrochloric Acid SCHEMBL14779247 0.98 DPP4 (0.43) DPP4DPP8DPP9DPP7FAP
Trifluoroacetic Acid SCHEMBL2496970 0.87 DPP4 (0.48) DPP4DPP8DPP9DPP7
SCHEMBL8613006 0.80 DPP4 (0.43) DPP4DPP8DPP9DPP7
SCHEMBL8613010 0.80 DPP4 (0.43) DPP4DPP8DPP9DPP7
SCHEMBL476156 0.79 DPP4 (0.40) DPP4DPP8DPP9DPP7
SCHEMBL13490222 0.79 DPP4 (0.41) DPP4DPP8DPP9DPP7FAP
SCHEMBL28004804 0.79 DPP4 (0.40) DPP4DPP8DPP9DPP7
Hydrochloric Acid SCHEMBL8615969 0.78 DPP4 (0.42) DPP4DPP8DPP9DPP7
Hydrochloric Acid SCHEMBL8615960 0.78 DPP4 (0.42) DPP4DPP8DPP9DPP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023129518-A1 TUBULYSINS AND PROTEIN-TUBULYSIN CONJUGATES REGENERON PHARMACEUTICALS, INC. (US) 2023-07-06 WO disclosed
US-9409952-B2 Peptide-compound cyclization method CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2016-08-09 US disclosed
WO-2013018929-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2013-02-07 WO disclosed
EP-1871379-A2 CYANOARYLAMINES Smithkline Beecham Corporation (US) 2008-01-02 EP disclosed
WO-2006113552-A2 CYANOARYLAMINES SMITHKLINE BEECHAM CORPORATION (US) 2006-10-26 WO disclosed